DCF — HILLCREST BAPTIST MEDICAL CENTER
Enterprise Value: $-518.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-518.3M
Enterprise Value
$-169.2M
PV of Cash Flows
$-349.1M
PV of Terminal Value
$-562.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $478.8M | $-29.5M | -6.0% | $-49.7M | $-45.2M |
| Year 2 | $493.2M | $-25.4M | -5.0% | $-46.3M | $-38.2M |
| Year 3 | $507.9M | $-21.1M | -4.0% | $-42.6M | $-32.0M |
| Year 4 | $523.2M | $-19.1M | -4.0% | $-41.2M | $-28.2M |
| Year 5 | $538.9M | $-18.3M | -3.0% | $-41.1M | $-25.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-518.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$464.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06651320548934316
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5